Alpha Tau Medical Ltd.

NASDAQ:DRTS

Biotechnology

Healthcare
$12.09 +0.42%

+$0.04 today

Market cap
$1.12B
Beta
1.20
P/E (TTM)
-15.2
EPS (TTM)
-$0.63
52W Low $2.85High $11.62

Volume 1.08M

Average 0.69M

Returns on capital

Alpha Tau Medical Ltd. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-55.3%

avg 628.1%

ROIC

-43.5%

avg -23.2%

ROA

-40.0%

avg -34.3%

Analysis

ROA is currently the strongest return metric at -40.0% versus its period average of -34.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Uzi Sofer

Chief Executive Officer & ChairmanUSD 1.26M564.68K<0.01%

Raphi Levy

Chief Financial OfficerUSD 763K4190.18K0.10%

Robert Den

Chief Medical Officer & Member of Scientific Advisory BoardUSD 756K47——

Ronen Segal

Chief Technology OfficerUSD 435K53——

Amnon Gat

Chief Operations OfficerUSD 251K51——

Yael Zeiger

Corporate Controller—43——

Rebecca Becker

Vice President of legal————

Yona Keisari

Chief Scientific Officer—79——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 21, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

12

$1.56M

Net Transaction Value

−$1.56M

Net selling

Most Active

Levy Raphi

12 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 21, 26

Levy Raphi

Direct

Sell$43.1K
Aug 11, 26

Levy Raphi

Direct

Sell$248.3K
Jul 6, 26

Levy Raphi

Direct

Sell$31.8K
Jul 2, 26

Levy Raphi

Direct

Sell$232.4K
Jul 1, 26

Levy Raphi

Direct

Sell$27.7K
Jun 30, 26

Levy Raphi

Direct

Sell$240K
Jun 25, 26

Levy Raphi

Direct

Sell$46.4K
Jun 25, 26

Levy Raphi

Direct

Sell$173.6K
Jun 23, 26

Levy Raphi

Direct

Sell$25K
Jun 23, 26

Levy Raphi

Direct

Sell$142.1K

1–10 of 12

Summary

Insiders reported 0 buys worth $0.00 and 12 sells worth $1.56M over the last 12 months. That adds up to net selling of $1.56M. Levy Raphi was the most active insider with 12 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Alpha Tau Medical Ltd. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about DRTS's management, answered from reported figures.

Who manages DRTS?

Alpha Tau Medical Ltd. (DRTS) lists 8 active executives. The top listed executive is Yael Zeiger, Corporate Controller.

Are DRTS insiders buying or selling?

Recent insider activity shows net selling of $1.43M.